122 filings
8-K
SLNO
Soleno Therapeutics Inc
29 Apr 24
First Ever Breakthrough Designation for a Drug Being Developed for PWS
4:08pm
8-K
SLNO
Soleno Therapeutics Inc
22 Apr 24
Departure of Directors or Certain Officers
4:15pm
8-K
SLNO
Soleno Therapeutics Inc
7 Mar 24
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
6:06am
8-K
SLNO
Soleno Therapeutics Inc
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
8-K
SLNO
Soleno Therapeutics Inc
5 Jan 24
Departure of Directors or Certain Officers
4:16pm
8-K
d7ihor3nzck0t0g9u
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
yf5m96p
27 Sep 23
Termination of a Material Definitive Agreement
5:23pm
8-K
x64khy4op43xm9q
26 Sep 23
Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from
7:30am
8-K
zu1z5qtj5vjk630uu
16 Aug 23
Departure of Directors or Certain Officers
9:00am
8-K
b0xndnrzm9 sn6bj6h
8 Aug 23
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:25pm
8-K
v7enbetpyrdxzrw
10 Jul 23
Regulation FD Disclosure
4:06pm
8-K
jqfyo604np7jbsuybhh8
26 May 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
m0xp2yzikxx
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
zbh4z5o3
3 May 23
Soleno Therapeutics Completes Enrollment in Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
5:26pm
8-K
7piyqyl yi6gv0pv2rbm
21 Mar 23
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
4:05pm
8-K
wsa5c43a ynwo5w
24 Feb 23
Departure of Directors or Certain Officers
4:06pm
8-K
y11fdep0ru 6o1
30 Jan 23
Departure of Directors or Certain Officers
6:05am
8-K
67cxyfih 1xkk
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
nmxigk dtxwzu
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
8-K
2a3anhn6w4
3 Oct 22
Soleno Therapeutics Announces Initiation of Randomized Withdrawal Study of
9:00am